During the past decade, Ospedale San Luca conducted 8 clinical trials. In the 10-year time frame, 8 clinical trials started and 3 clinical trials were completed, i.e. on average, 37.5% percent of trials that started reached the finish line to date. In the past 5 years, 4 clinical trials started and 2 clinical trials were completed. i.e. 50% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Ospedale San Luca" #1 sponsor was "Bristol-Myers Squibb" with 2 trials, followed by "Daiichi Sankyo, Inc." with 2 trials sponsored, "Gruppo Oncologico del Nord-Ovest" with 2 trials sponsored, "Pfizer" with 2 trials sponsored and "Arcagy Research" with 2 trials sponsored. Other sponsors include -1 different institutions and companies that sponsored additional 9 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Ospedale San Luca" #1 collaborator was "Arbeitsgemeinschaft Gynaekologische Onkologie Austria" with 1 trials as a collaborator, "Arbeitsgemeinschaft Gynaekologishe Onkologie Germany" with 1 trials as a collaborator, "AstraZeneca" with 1 trials as a collaborator, "Belgian Gynaecological Oncology Group" with 1 trials as a collaborator and "Clinical Research Technology S.r.l." with 1 trials as a collaborator. Other collaborators include 2 different institutions and companies that were collaborators in the rest 12 trials.

According to Clinical.Site data, the most researched conditions in "Ospedale San Luca" are "Carcinoma, Non-Small-Cell Lung" (2 trials), "Non-Small Cell Lung Cancer" (2 trials), "Breast Cancer" (1 trials), "Colorectal Cancer" (1 trials) and "EGFR Exon 19 Deletion" (1 trials). Many other conditions were trialed in "Ospedale San Luca" in a lesser frequency.

Most popular intervention types in "Ospedale San Luca" are "Drug" (12 trials), "Biological" (2 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Carboplatin" (2 trials), "Nivolumab" (2 trials), "PF-02341066" (2 trials), "Paclitaxel" (2 trials) and "Pemetrexed" (2 trials). Other intervention names were less common.

The vast majority of trials in "Ospedale San Luca" are 10 trials for "All" genders and 3 trials for "Female" genders.

Currently, there are NaN active trials in "Ospedale San Luca". undefined are not yet recruiting, 2 are recruiting, 4 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 7 completed trials in Ospedale San Luca, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Ospedale San Luca, 0 "Phase 1" clinical trials were conducted, 3 "Phase 2" clinical trials and 9 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".